Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: A randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 312, Issue 21, 2014, Pages 2244-2253

  Bove, Tiziana ^a   Zangrillo, Alberto ^a,s   Guarracino, Fabio ^b   Alvaro, Gabriele ^c   Persi, Bruno ^d   Maglioni, Enivarco ^e   Galdieri, Nicola ^f   Comis, Marco ^g   Caramelli, Fabio ^h   Pasero, Daniela C ⁱ   Pala, Giovanni ^j   Renzini, Massimo ^k   Conte, Massimiliano ^l   Paternoster, Gianluca ^m   Martinez, Blanca ⁿ   Pinelli, Fulvio ^o   Frontini, Mario ^p   Zucchetti, Maria C ^q   Pappalardo, Federico ^a   Amantea, Bruno ^c   Camata, Annamaria ^d   Pisano, Antonio ^f   Verdecchia, Claudio ^g   Dal Checco, Erika ^h   Cariello, Claudia ^b   Faita, Luana ^c   Baldassarri, Rubia ^b   Scandroglio, Anna M ^a   Saleh, Omar ^a   Lembo, Rosalba ^a   Calabrò, Maria G ^a   Bellomo, Rinaldo ^r   Landoni, Giovanni ^a,s   more..

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

^c Policlinico Mater Domini   (Italy)

^d OSPEDALE CA FONCELLO   (Italy)

^e Siena Hospital   (Italy)

^f MONALDI HOSPITAL   (Italy)

^g MAURIZIANO HOSPITAL   (Italy)

^h UNIVERSITY OF BOLOGNA   (Italy)

ⁱ UNIVERSITY OF TURIN   (Italy)

^j SS Annunziata Hospital   (Italy)

^k SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^l GVM Care Research   (Italy)

^m A O Regionale San Carlo   (Italy)

ⁿ SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^o CAREGGI UNIVERSITY HOSPITAL   (Italy)

^p SPEDALI CIVILI   (Italy)

^q Ospedali Riuniti Papardo Piemonte Hospital   (Italy)

^r MONASH UNIVERSITY   (Australia)

^s VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FENOLDOPAM; PLACEBO; VASODILATOR AGENT;

ACUTE KIDNEY FAILURE; AGED; ARTERIAL PRESSURE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; FEMALE; HEART SURGERY; HUMAN; HYPOTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OLIGURIA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME; CHEMICALLY INDUCED; CLINICAL TRIAL; CRITICAL ILLNESS; INTENSIVE CARE UNIT; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROCEDURES; UNITED STATES;

ACUTE KIDNEY INJURY; AGED; CARDIAC SURGICAL PROCEDURES; CREATININE; CRITICAL ILLNESS; DOUBLE-BLIND METHOD; FEMALE; FENOLDOPAM; HUMANS; HYPOTENSION; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RENAL REPLACEMENT THERAPY; UNITED STATES; VASODILATOR AGENTS;

EID: 84914673923     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.13573     Document Type: Article

References (35)

1. Go AS, Mozaffarian D, Roger VL, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28-e292.
2. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104(4):343-348.
3. Uchino S, Kellum JA, Bellomo R, et al; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813-818.
4. Singer I, Epstein M. Potential of dopamine A-1 agonists in the management of acute renal failure. Am J Kidney Dis. 1998;31(5):743-755.
5. Aravindan N, Samuels J, Riedel B, Shaw A. Fenoldopam improves corticomedullary oxygen delivery and attenuates angiogenesis gene expression in acute ischemic renal injury. Kidney Blood Press Res. 2006;29(3):165-174.
6. Tumlin JA, Finkel KW, Murray PT, Samuels J, Cotsonis G, Shaw AD. Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis. 2005;46(1):26-34.
7. Yi X, Zhang G, Yuan J. Renoprotective role of fenoldopam pretreatment through hypoxia-inducible factor-1alpha and heme oxygenase-1 expressions in rat kidney transplantation. Transplant Proc. 2013;45(2):517-522.
8. Landoni G, Biondi-Zoccai GG, Tumlin JA, et al. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: ameta-analysis of randomized clinical trials. Am J Kidney Dis. 2007;49(1):56-68.
9. Garg AX, Devereaux PJ, Yusuf S, et al; CORONARY Investigators. Kidney function after off-pump or on-pump coronary artery bypass graft surgery: a randomized clinical trial. JAMA. 2014;311(21):2191-2198. doi:10.1001/jama.2014.4952.
10. Mao H, Katz N, AriyanonW, et al. Cardiac surgery-associated acute kidney injury. Cardiorenal Med. 2013;3(3):178-199.
11. Schetz M, Bove T, Morelli A, Mankad S, Ronco C, Kellum JA. Prevention of cardiac surgery-associated acute kidney injury. Int J Artif Organs. 2008;31(2):179-189.
12. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204-R212.
13. Landoni G, Bove T, Pasero D, et al. Fenoldopam to prevent renal replacement therapy after cardiac surgery: design of the FENO-HSR study. HSR Proc Intensive Care Cardiovasc Anesth. 2010;2(2):111-117.
14. Bove T, Paternoster G, ConteM. The FENO-HSR study: details of statistical analyses. HSR Proc Intensive Care Cardiovasc Anesth. 2013;5(1):55-56.
15. ICH harmonised tripartite guideline: guideline for good clinical practice: 8, essential documents for the conduct of a clinical trial. J Postgrad Med. 2001;47(4):264-267.
16. Landoni G, Biondi-Zoccai GG, Marino G, et al. Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: ameta-analysis. J Cardiothorac Vasc Anesth. 2008;22(1):27-33.
17. Reboussin DM, De Mets DL, Kim K, Lan KKG. Programs for computing group sequential boundaries using the Lan-De Mets Method [technical report 60]. Department of Biostatistics, University ofWisconsin, Madison; 1992.
18. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika. 1983;70:659-663.
19. Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative renal risk stratification. Circulation. 1997;95(4):878-884.
20. Thakar CV, Arrigain S, Worley S, Yared J-P, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005;16(1):162-168.
21. Mehta RH, Grab JD, O'Brien SM, et al; Society of Thoracic Surgeons National Cardiac Surgery Database Investigators. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation. 2006;114(21):2208-2216.
22. Wijeysundera DN, Karkouti K, Dupuis J-Y, et al. Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA. 2007;297(16):1801-1809.
23. Ricci Z, Luciano R, Favia I, et al. High-dose fenoldopam reduces postoperative neutrophil gelatinase-associated lipocaline and cystatin C levels in pediatric cardiac surgery. Crit Care. 2011;15(3):R160.
24. Cogliati AA, Vellutini R, Nardini A, et al. Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study. J Cardiothorac Vasc Anesth. 2007;21(6):847-850.
25. Halpenny M, Lakshmi S, O'Donnell A, O'Callaghan-Enright S, Shorten GD. Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting. Anaesthesia. 2001;56(10):953-960.
26. Caimmi PP, Pagani L, Micalizzi E, et al. Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2003;17(4):491-494.
27. Ranucci M, De Benedetti D, Bianchini C, et al. Effects of fenoldopam infusion in complex cardiac surgical operations: a prospective, randomized, double-blind, placebo-controlled study. Minerva Anestesiol. 2010;76(4):249-259.
28. O'Hara JF Jr, Mahboobi R, Novak SM, et al. Fenoldopam and renal function after partial nephrectomy in a solitary kidney: a randomized, blinded trial. Urology. 2013;81(2):340-345.
29. Landoni G, Augoustides JG, Guarracino F, et al. Mortality reduction in cardiac anesthesia and intensive care: results of the First International Consensus Conference. HSR Proc Intensive Care Cardiovasc Anesth. 2011;3(1):9-19.
30. Tumlin JA. Impaired blood flow in acute kidney injury: pathophysiology and potential efficacy of intrarenal vasodilator therapy. Curr Opin Crit Care. 2009;15(6):514-519.
31. Landoni G, Bove T, Székely A, et al. Reducing mortality in acute kidney injury patients: systematic review and international web-based survey. J Cardiothorac Vasc Anesth. 2013;27(6):1384-1398.
32. Bove T, Monaco F, Covello RD, Zangrillo A. Acute renal failure and cardiac surgery. HSR Proc Intensive Care Cardiovasc Anesth. 2009;1(3):13-21.
33. Mathur VS, Swan SK, Lambrecht LJ, et al. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med. 1999;27(9):1832-1837.
34. Meco M, Allaz MC, Cirri S. Effects of fenoldopam mesylate infusion on splanchnic perfusion after myocardial revascularization on cardiopulmonary bypass: an ultrasound Doppler study. J Cardiothorac Vasc Anesth. 2011;25(4):642-646.
35. Bellomo R, Bagshaw SM. Evidence-based medicine: classifying the evidence from clinical trials: the need to consider other dimensions. Crit Care. 2006;10(5):232.